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In the previous issue of Critical Care, Protti and 
colleagues presented a series of patients with severe 
hyperlactatemia secondary to biguanide intoxication [1]. 
Traditionally, hyperlactatemia in critically ill patients – 
and particularly those in shock – was normally inter-
preted as a marker of secondary anaerobic metabolism 
due to inadequate oxygen supply inducing cellular 
distress [2]. Th   is view has recently been challenged with 
the demonstration that, during shock states, lactate 
production is, at least in part, linked to an increased 
aerobic glycolysis through β2 stimulation [3]. We recently 
demonstrated in a rat model that this mechanism occurs 
not only during sepsis (high or normal blood ﬂ  ow), but 
also during hemorrhagic shock (low blood ﬂ  ow) [4].
In clinical practice, there are clearly certain situations 
where hyperlactatemia is predominantly a reﬂ  ection of 
tissue hypoperfusion with subsequent anaerobic metabo-
lism. Shock states induced by low cardiac output should 
theoretically be accompanied by hypoxic hyperlac-
tatemia. Cardiogenic shock, as demonstrated previously 
[5], is associated with hyperlactatemia with a very high 
lactate/pyruvate ratio. In theory, hemorrhagic shock 
should behave in an identical fashion. Nevertheless, 
hemorrhagic shock, when prolonged, becomes an inﬂ  am-
matory shock and may therefore behave as septic shock.
Th   e problem encountered with sepsis is more complex, 
although at least two situations are usually accompanied 
with hypoxia-associated hyperlactatemia. Th  e  ﬁ  rst 
situation is septic shock with catecholamine-resistant 
cardiocirculatory failure, especially in situations of low 
cardiac output. Th   e second circumstance is septic shock 
pre-emptively observed prior to volumetric expansion, as 
illustrated in the study of Rivers and colleagues in which 
hyperlactatemia was associated with signs of poor oxygen 
delivery [6]. Th   ese two situations are nonetheless close to 
low-output states.
By deﬁ  nition, hypoxia blocks mitochondrial oxidative 
phosphorylation [7], thereby inhibiting ATP synthesis 
and reoxidation of NADH. Th   is leads to a decrease in the 
ATP/ADP ratio and an increase in the NADH/NAD 
ratio. A decrease in the ATP/ADP ratio induces both an 
accumulation of pyruvate, which cannot be utilized by 
way of phosphofructokinase stimulation, and a decrease 
in pyruvate utilization by inhibiting pyruvate carboxylase, 
which converts pyruvate into oxaloacetate. An increased 
NADH/NAD ratio also increases pyruvate by inhibiting 
pyruvate dehydrogenase, and hence its conversion into 
acetylcoenzyme A.
Consequently, the increase in lactate production in an 
anaerobic setting is the result of an accumulation of 
pyruvate that is converted into lactate, which stems from 
alterations in the redox potential. Th   is conversion allows 
for the regeneration of some NAD+, enabling the 
production of ATP by anaerobic glycolysis – although the 
process is clearly less eﬃ   cient from an energy standpoint 
(two ATP molecules produced versus 36). It is important 
to consider that the modiﬁ  cation of the redox potential 
induced by an increase in the NADH/NAD ratio activates 
the transformation of pyruvate into lactate, and 
consequently increases the lactate/pyruvate ratio [8].
All in all, anaerobic energy metabolism is characterized 
by hyperlactatemia associated with an elevated lactate/
pyruvate ratio, greater glucose utilization and low energy 
production [9].
Th  e exact mechanism of biguanide-induced lactic 
acidosis is not well understood. Th   is infrequent compli-
cation is associated with high mortality. Biguanide drugs 
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Biguanide poisoning is associated with lactic acidosis. 
The exact mechanism of biguanide-induced lactic 
acidosis is not well understood. In the previous issue of 
Critical Care, Protti and colleagues demonstrated that 
biguanide-induced lactic acidosis may be due in part 
to a reversible inhibition of mitochondrial respiration. 
Thus, in the absence of an antidote, increased drug 
elimination through dialysis is logical.
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© 2010 BioMed Central Ltdmainly exert their therapeutic eﬀ  ect by impairing hepato-
cyte mitochondrial respiration [10]. Recent observations 
have suggested that metformin, similarly to phenformin, 
may also inhibit mitochondrial respiration in tissues 
other than the liver [11].
In the previous issue of Critical Care, using indirect 
measurement of oxygen consumption, Protti and 
colleagues found that body oxygen consumption was 
markedly depressed despite a normal cardiac index 
evoking an inhibition of mitochondrial respiration [1]. 
Unfortunately, arterial lactate/pyruvate and acetoacetate/
β-hydroxybutyrate ratios, as reﬂ   ections of cytoplasmic 
and mitochondrial redox states, were unavailable. 
Interestingly, there was a clear correlation between drug 
clearance, correction of lactic acidosis and normalization 
of oxygen consumption. Clearly, the inhibition of mito-
chondrial respiration is not the unique mechanism 
involved in biguanide-induced lactic acidosis, since pure 
inhibition of mitochondrial function during cyanide 
poisoning is associated with death in the absence of 
antidote [12], and, similarly, since lactic acidosis asso-
ciated with the use of nucleoside analogue reverse trans-
criptase inhibitors is due to an impairment of mito  chon-
drial oxidative phosphorylation and is also associated 
with high mortality despite prompt therapy [13].
To conclude, when looking at the literature, pure 
hypoxic causes of lactic acidosis are relatively rare in 
clinical practice. In the case of biguanide-induced lactic 
acidosis, the fact that the inhibition of mitochondrial 
respiration is reversible should encourage the early use of 
dialysis [14] in order to accelerate drug elimination.
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